On the public citation graph

Liposome-based high-throughput and point-of-care assays toward the quick, simple, and sensitive detection of neutralizing antibodies against SARS-CoV-2 in patient sera

0 signed · 58 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/anie.201708630openalex-snapshot
Electrochemiluminescence Bioassays with a Water‐Soluble Luminol Derivative Can Outperform Fluorescence Assays
inferredcites →https://doi.org/10.1002/jmv.28164openalex-snapshot
Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster
inferredcites →https://doi.org/10.1007/s00216-008-1992-1openalex-snapshot
Universal liposomes: preparation and usage for the detection of mRNA
inferredcites →https://doi.org/10.1007/s00216-013-6807-3openalex-snapshot
Superior performance of liposomes over enzymatic amplification in a high-throughput assay for myoglobin in human serum
inferredcites →https://doi.org/10.1007/s00216-013-7020-0openalex-snapshot
Multi-channel PMMA microfluidic biosensor with integrated IDUAs for electrochemical detection
inferredcites →https://doi.org/10.1007/s00216-021-03750-5openalex-snapshot
Highly sensitive interleukin 6 detection by employing commercially ready liposomes in an LFA format
inferredcites →https://doi.org/10.1007/s00216-022-04416-6openalex-snapshot
Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
inferredcites →https://doi.org/10.1007/s15010-020-01503-7openalex-snapshot
A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization
inferredcites →https://doi.org/10.1016/j.bbrc.2020.10.012openalex-snapshot
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
inferredcites →https://doi.org/10.1016/j.bios.2021.113883openalex-snapshot
Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
inferredcites →https://doi.org/10.1016/j.bios.2022.114034openalex-snapshot
Versatile role of ACE2-based biosensors for detection of SARS-CoV-2 variants and neutralizing antibodies
inferredcites →https://doi.org/10.1016/j.cell.2020.02.058openalex-snapshot
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
inferredcites →https://doi.org/10.1016/j.cell.2020.11.032openalex-snapshot
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
inferredcites →https://doi.org/10.1016/j.cell.2020.12.015openalex-snapshot
COVID-19 Neutralizing Antibodies Predict Disease Severity and Survival
inferredcites →https://doi.org/10.1016/j.crmeth.2022.100273openalex-snapshot
Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer
inferredcites →https://doi.org/10.1016/j.dyepig.2013.06.011openalex-snapshot
Binding of sulforhodamine B to human serum albumin: A spectroscopic study
inferredcites →https://doi.org/10.1016/j.jcv.2021.105024openalex-snapshot
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
inferredcites →https://doi.org/10.1016/s1473-3099(20)30843-4openalex-snapshot
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
inferredcites →https://doi.org/10.1021/acssensors.2c02067openalex-snapshot
A Four-Channel Surface Plasmon Resonance Sensor Functionalized Online for Simultaneous Detections of Anti-SARS-CoV-2 Antibody, Free Viral Particles, and Neutralized Viral Particles
inferredcites →https://doi.org/10.1038/s41467-020-17892-0openalex-snapshot
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
inferredcites →https://doi.org/10.1038/s41467-020-19619-7openalex-snapshot
SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography
inferredcites →https://doi.org/10.1038/s41467-020-20247-4openalex-snapshot
Neutralizing antibody titres in SARS-CoV-2 infections
inferredcites →https://doi.org/10.1038/s41467-022-31300-9openalex-snapshot
Homogeneous surrogate virus neutralization assay to rapidly assess neutralization activity of anti-SARS-CoV-2 antibodies
inferredcites →https://doi.org/10.1038/s41586-020-2349-yopenalex-snapshot
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
inferredcites →https://doi.org/10.1038/s41586-020-2381-yopenalex-snapshot
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
inferredcites →https://doi.org/10.1038/s41586-020-2852-1openalex-snapshot
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
inferredcites →https://doi.org/10.1038/s41591-020-0965-6openalex-snapshot
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
inferredcites →https://doi.org/10.1038/s41591-021-01449-9openalex-snapshot
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
inferredcites →https://doi.org/10.1038/s43856-021-00045-9openalex-snapshot
A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
inferredcites →https://doi.org/10.1056/nejmoa2026920openalex-snapshot
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
inferredcites →https://doi.org/10.1056/nejmoa2034577openalex-snapshot
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
inferredcites →https://doi.org/10.1080/22221751.2020.1743767openalex-snapshot
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
inferredcites →https://doi.org/10.1126/science.abb7269openalex-snapshot
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
inferredcites →https://doi.org/10.1126/science.abh1139openalex-snapshot
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
inferredcites →https://doi.org/10.1126/scitranslmed.abi8452openalex-snapshot
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma
inferredcites →https://doi.org/10.1371/journal.ppat.1009089openalex-snapshot
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
inferredcites →https://doi.org/10.3390/diagnostics11101843openalex-snapshot
Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation
inferredcites →https://doi.org/10.3390/v13061118openalex-snapshot
Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020
inferredcites →https://doi.org/10.3390/v14061168openalex-snapshot
Time Trend in SARS-CoV-2 Seropositivity, Surveillance Detection- and Infection Fatality Ratio until Spring 2021 in the Tirschenreuth County—Results from a Population-Based Longitudinal Study in Germany
inferredcites →https://doi.org/10.3390/vaccines10020271openalex-snapshot
A Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader for SARS-CoV-2 Neutralizing Antibody Detection
inferredcites →https://doi.org/10.3390/vaccines10020324openalex-snapshot
Comparative Immunogenicity of COVID-19 Vaccines in a Population-Based Cohort Study with SARS-CoV-2-Infected and Uninfected Participants
inferredcites →https://doi.org/10.3390/vaccines9010013openalex-snapshot
Comparison of Four SARS-CoV-2 Neutralization Assays

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4604790openalex-extracted
Colorimetric Sensor Based on Release Control from Liposomes by the Formation of 2,2-Bipyridine-Fe 2 Complex
inferred← citeshttps://doi.org/10.1002/smll.202505312openalex-snapshot
Encapsulants Affect Liposome Surface Interactions with Biological Systems
inferred← citeshttps://doi.org/10.1007/s00216-025-05882-4openalex-snapshot
A homogeneous immunoassay technology based on liposomes and the complement system enables one-step, no-wash, rapid diagnostics directly in serum
inferred← citeshttps://doi.org/10.1007/s00216-026-06865-9openalex-snapshot
Development of a highly sensitive photometric readout platform technology using SPAAC-modified HRP liposomes
inferred← citeshttps://doi.org/10.1016/j.ejpb.2023.10.003openalex-snapshot
Modulation of immune responses to liposomal vaccines by intrastructural help
inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.05.034openalex-snapshot
Lipid conjugate dissociation analysis improves the in vivo understanding of lipid-based nanomedicine
inferred← citeshttps://doi.org/10.1016/j.microc.2024.110316openalex-snapshot
Colorimetric sensor based on release control from liposomes by the formation of 2,2-bipyridine-Fe2+ complex
inferred← citeshttps://doi.org/10.1016/j.microc.2026.117081openalex-snapshot
Liposome-based biosensors : advanced signal amplification strategies and emerging applications in clinical diagnostics and environmental monitoring
inferred← citeshttps://doi.org/10.1016/j.snr.2025.100336openalex-snapshot
Microfluidic immunoassay for the detection of SARS-CoV-2 neutralizing antibodies in ultralow-volume human plasma samples
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c00666openalex-snapshot
Advances in Surrogate Neutralization Tests for High-Throughput Screening and the Point-of-Care
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c02526openalex-snapshot
Development of a Liposome-Based Serological Assay for SARS-CoV-2 Variants with Special Emphasis on Coupling Chemistries Required to Maintain Protein Antigenicity
inferred← citeshttps://doi.org/10.1021/acs.analchem.5c04506openalex-snapshot
Development of a Novel Homogeneous Liposome-Based One-Step Assay for SARS-CoV-2 Antibody Detection in Human Serum Based on Fluorescent Liposomes and Complement Activity
inferred← citeshttps://doi.org/10.1021/acs.analchem.6c00320openalex-snapshot
His-Tag-Aptamer-Liposome-Conjugates as a Multipurpose Tool for Recombinant Protein Screening and Protein-Based Bioassays
inferred← citeshttps://doi.org/10.1021/acs.analchem.6c01867openalex-snapshot
Wearable Eye Patch Paper Biosensor for Sensitive Dual-Modal Quantification of Cortisol and Dehydroepiandrosterone in Human Tear: A Noninvasive Point-of-Care Depression Screening
inferred← citeshttps://doi.org/10.1038/s41598-025-19009-3openalex-snapshot
Development and characterization of a human papillomavirus-based nanoparticle carrier for heterologous vaccine antigens
inferred← citeshttps://doi.org/10.1093/chemle/upae166openalex-snapshot
Cholesterol-end-modified–PEG vesicle: DDS carrier with long-term stability to encapsulate a drug model by facile preparation
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.